Concert Health is a behavioral health medical group that delivers integrated behavioral health services to primary care, pediatrics, and women’s health practices using the evidence-based Collaborative Care model. Its core product is a turnkey service combining an expert clinical team and a technology platform that embeds behavioral health clinicians into existing care teams to improve outcomes for depression and anxiety. The company reports it has served over 27,000 patients to date, with 55% covered by Medicaid or Medicare, and partners with 54 medical groups across 11 states. Concert says its model reduces symptoms, increases medication adherence, and raises patient satisfaction, and the organization plans to expand into Arkansas, Massachusetts, and Washington this quarter while scaling nationwide. The company works with health systems, Federally Qualified Health Centers, Rural Health Clinics, and independent medical groups to reach underserved and vulnerable populations. Concert is headquartered in San Diego and emphasizes improving value-based care outcomes through integrated behavioral health. Concert Health provides turnkey behavioral health services combining expert Behavioral Care Managers, psychiatrists, and a technology platform to embed Collaborative Care Management (CoCM) into primary care and women’s health. Since 2018 the company has scaled partnerships with 44 medical groups and health systems and supports over 800 physicians across seven states. Its model delivers measurable outcomes—over 60% of patients have seen depression or anxiety symptoms reduce by half within the first 90 days. Concert’s services are reimbursed as a covered benefit for Medicare, most commercial insurers, and Medicaid programs in 18 states. The company plans to use new capital to expand its clinical, technology, and commercial teams and rapidly scale services in primary care and women’s health settings. Concert also partners with large systems including CommonSpirit Health to broaden access to its model.

Total raised

$56M

Funding rounds

3

Latest round

Series B

Latest activity

Apr 2022